A mighty wind: Chinook, Aduro to merge, with focus on kidney disease June 2, 2020 By Lee Landenberger No Comments Aduro Biotech Inc. and privately held Chinook Therapeutics Inc., will merge to focus mainly on kidney diseases. Two complementary drugs are involved in the deal.Read More